hypernatraemia and diabetes insipidus
Hypernatraemia = water deficit relative to sodium, almost always from no access to water (intubated, delirious, frail) plus losses. Lower chronic hypernatraemia by ~10 mmol/L/day, mostly with enteral water or D5W; adults are more often undertreated than overcorrected. Hypotonic polyuria (>3 L/day or >40–50 mL/kg/day, urine <800 mOsm/kg) → AVP deficiency (central DI) vs AVP resistance (nephrogenic DI) vs primary polydipsia. Stimulated copeptin has replaced the water-deprivation test where available.
- Acute salt poisoning (minutes–hours: salt ingestion, hypertonic saline, dialysis error) → rapid D5W + emergency haemodialysis; risk is intracranial haemorrhage, not overcorrection
- Post-pituitary surgery DI in a patient who can’t drink → hypernatraemia within hours
- Undertreatment: cerebral oedema from fast correction is reported only in children; adults are usually undertreated
causes
| mechanism | examples | urine osm (mOsm/kg) |
|---|---|---|
| renal water loss | AVP-D, AVP-R, osmotic diuresis (glucose, urea, mannitol, post-obstruction) | <300 (DI) or 300–600 (osmotic) |
| extrarenal water loss | fever, burns, ventilation, diarrhoea | high (>600–700) |
| poor intake | impaired thirst or access (elderly, ICU, hypothalamic lesion) | high |
| sodium gain | hypertonic saline, NaHCO₃, salt ingestion | variable |
correction
TBW ≈ 0.6 × weight (young men), 0.5 (women, older men), 0.45 (older women). Add ongoing renal and insensible losses. Rule of thumb: 3 mL/kg electrolyte-free water lowers Na⁺ ~1 mmol/L (no ongoing urine water loss). Monitor Na⁺ rather than trusting the formula.
| onset | typical cause | target |
|---|---|---|
| minutes–hours | salt poisoning | rapid D5W + emergency HD; overcorrection not known to harm |
| 1–2 days | unreplaced urine water (DI, glycosuria) | lower ~2 mmol/L/h to 145; replace or stop ongoing losses |
| ≥2 days or unknown | hypodipsia, impaired mental status | lower ~10 mmol/L/day; replace ongoing losses |
- The ≤0.5 mmol/L/h limit comes from rehydration seizures in children; no adult limit is established
- Enteral free water if the gut works; otherwise D5W (watch glucose)
- Hypovolaemic and shocked: isotonic fluid first, then water
- Na⁺ every 4–6 h while correcting
polyuria and DI
2022 nomenclature: arginine vasopressin deficiency (AVP-D) = central DI; arginine vasopressin resistance (AVP-R) = nephrogenic DI.
| AVP-D (central) | AVP-R (nephrogenic) | |
|---|---|---|
| causes | pituitary/hypothalamic surgery, trauma, craniopharyngioma, infiltrative (sarcoid, LCH), idiopathic | lithium, hypercalcaemia, hypokalaemia, tubulointerstitial disease, post-obstruction, congenital (AVPR2, AQP2) |
| response to desmopressin | urine osm rises >50%, volume falls | little or none |
| treatment | desmopressin (µg doses: e.g. intranasal 10–20 µg, oral 100–400 µg/day) | treat the cause (correct Ca²⁺, K⁺); low-solute (low Na, low protein) diet; thiazide; amiloride for lithium |
- Confirm hypotonic polyuria on a 24-h collection. Urine osm >800 → solute diuresis (glucose incl. SGLT2i, urea from protein/catabolism/steroids, mannitol, diuretics), not DI
- Baseline bloods: Na⁺ >147 / osm ≥300 → AVP-D or AVP-R; Na⁺ <135 / osm ≤280 → primary polydipsia (desmopressin dangerous here → hyponatraemia). Most patients are in between and need testing
- Already hypernatraemic (Na⁺ >147) with hypotonic polyuria → the osmotic stimulus is already there, so no deprivation or stimulation test: copeptin ≤4.9 pmol/L = AVP-D, >21.4 = AVP-R. Without copeptin, the desmopressin response (urine osm rise >50% = AVP-D) is the usual substitute
| test | result | interpretation |
|---|---|---|
| basal copeptin (unstressed) | >21.4 pmol/L | AVP-R |
| hypertonic saline-stimulated copeptin (3% 250 mL over 15 min, then weight-adapted infusion; Na⁺ every 30 min; sample once >149) | ≤4.9 pmol/L | AVP-D (accuracy 96–97%) |
| >4.9 pmol/L | primary polydipsia | |
| arginine-stimulated copeptin (0.5 g/kg in 500 mL NS over 30 min) | ≤3.0 / >5.2 pmol/L | AVP-D / primary polydipsia (in between → indeterminate) |
| water deprivation (≥16 h) then desmopressin | urine <300 → rise >50% / <50% | complete AVP-D / AVP-R |
| urine 300–800 → rise ≥9% / <9% | partial AVP-D / partial AVP-R or primary polydipsia |
-
Water deprivation accuracy only ~77%: often fails to produce enough osmotic stimulus. Hypertonic saline needs rapid Na⁺ turnaround and continuous monitoring; arginine is shorter (1 h) and better tolerated. Canadian copeptin availability is limited
-
Desmopressin hyponatraemia: ~30% of outpatients with AVP-D on routine bloods. Start with a night-time dose; check Na⁺ in the first days; counsel against excess drinking. Desmopressin escape: delay or omit a dose weekly to allow an aquaresis
-
AVP-D patients drinking to thirst rarely get hypernatraemic. Risk is when thirst or access is lost: surgery, reduced consciousness, adipsic AVP-D (hypothalamic osmoreceptor damage)
- Desmopressin 2–4 µg IV/SC
- Lithium AVP-R: amiloride blocks lithium entry via ENaC in the collecting duct
- Thiazides reduce polyuria in AVP-R through mild volume contraction and more proximal reabsorption (paradoxical)
Prepared 2026-10-27. Not yet verified — check every number against the sources.